药物诱导的B型肝炎病毒再激活:FAERS数据库分析的见解
Genshan Zhang1, Hanpeng Yan2, Haokun Zhang3
1Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Expert opinion on drug safety
|December 4, 2024
概括
药物诱导的乙型肝炎病毒 (HBV) 再激活是一个严重的风险. 一项研究确定了达克林扎和多克索鲁比辛等顶级药物,其中23种药物在文档中缺乏明确的HBV重新激活警告.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
背景情况:
- 药物诱导的乙型肝炎病毒 (HBV) 重活化是一个重大的临床问题.
- 它可能导致治疗中断,肝炎恶化,肝功能衰竭和死亡.
研究的目的:
- 通过不成比例性分析,识别具有HBV重新激活风险的药物.
- 突出关于HBV再激活的药物安全信息中的潜在差距.
主要方法:
- 分析了2017年1月至2023年12月的食品和药物管理局不良事件报告系统 (FAERS) 数据库.
- 使用不相称性分析 (ROR,PRR) 来检测药物诱导的HBV重新激活 (HBV-R).
- 通过MedDRA识别的HBV-R病例和通过DrugBank.
主要成果:
- 确定了2596份与药物诱导的HBV-R相关的不良事件报告.
- 鉴定到的顶级药物包括达克林扎,沃卡布里亚,多克索鲁比辛,索瓦尔迪和里巴维林.
- 前40名药物分为抗瘤,免疫抑制和抗病毒类别,其中23种药物缺乏明确的HBV-R警告.
结论:
- 一些药品在其文档中不充分地解决了HBV重新激活的风险.
- 这些发现可以帮助医疗保健提供者早期识别药物诱导的HBV-R.
更多相关视频
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
2.9K
11:36Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
2.9K
相关概念视频
01:19Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
01:17Hepatic Drug Excretion: Enterohepatic Cycling
1.0K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.0K